Mechanistically, Wnt/β-catenin signaling has been reported to down-regulate the metastasis suppressor gene kangai 1 (KAI1, also known as CD82) in prostate cancer cells to potentially facilitate metastatic progression, and KAI1 expression is frequently decreased in metastatic prostate cancer [224]. Here, CD82 is linked to prostate carcinoma.